Tetraphase Pharmaceu (TTPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -70,085 | -72,158 | -114,752 | -77,480 | -83,189 |
| Depreciation Amortization | 633 | 576 | 431 | 282 | 287 |
| Accounts receivable | 772 | 2,379 | -2,864 | 2,362 | -693 |
| Accounts payable and accrued liabilities | -781 | -2,096 | 2,751 | -302 | -1,249 |
| Other Working Capital | -3,094 | -1,320 | 4,308 | 287 | -5,468 |
| Other Operating Activity | 8,885 | 12,991 | 12,076 | 11,085 | 13,605 |
| Operating Cash Flow | $-63,670 | $-59,628 | $-98,050 | $-63,766 | $-76,707 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 478 | -204 | -771 | -393 | -838 |
| Purchase Sale Intangibles | N/A | -4,750 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -4,750 | 0 | 0 | 0 |
| Investing Cash Flow | $478 | $-4,954 | $-771 | $-393 | $-838 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 28,949 | N/A | N/A | N/A |
| Debt Repayment | -30,480 | 0 | N/A | 0 | -4,646 |
| Common Stock Issued | 7,135 | 7,498 | 93,146 | 333 | 167,061 |
| Financing Cash Flow | $-23,345 | $36,447 | $93,146 | $333 | $162,415 |
| Beginning Cash Position | 108,475 | 136,610 | 142,285 | 205,912 | 121,042 |
| End Cash Position | 21,938 | 108,475 | 136,610 | 142,086 | 205,912 |
| Net Cash Flow | $-86,537 | $-28,135 | $-5,675 | $-63,826 | $84,870 |
| Free Cash Flow | |||||
| Operating Cash Flow | -63,670 | -59,628 | -98,050 | -63,766 | -76,707 |
| Capital Expenditure | -108 | -204 | -771 | -393 | -838 |
| Free Cash Flow | -63,778 | -59,832 | -98,821 | -64,159 | -77,545 |